The 2018 ESC/EACTS guidelines on myocardial revascularization provide comprehensive recommendations for the diagnosis, treatment, and management of patients requiring myocardial revascularization. Developed by the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), with contributions from the European Association of Percutaneous Cardiovascular Interventions (EAPCI), these guidelines aim to improve clinical outcomes and quality of life for patients with coronary artery disease (CAD). The guidelines emphasize the importance of risk stratification, functional assessment of coronary lesions, and the selection of appropriate revascularization strategies, including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Key recommendations include the use of fractional flow reserve (FFR) to assess the functional significance of coronary stenoses, the role of the heart team in decision-making, and the importance of risk-adapted treatment approaches. The guidelines also address specific patient populations, such as those with diabetes, chronic kidney disease, and those requiring valve surgery. They highlight the need for individualized care, considering the patient's overall clinical status and comorbidities. The guidelines emphasize the importance of evidence-based practice, with a focus on the latest clinical research and data. They also provide detailed recommendations on the use of antithrombotic therapy, the management of acute coronary syndromes, and the optimization of revascularization techniques. The guidelines are intended to be used in conjunction with other clinical guidelines and should not replace the judgment of individual clinicians. The recommendations are based on a thorough analysis of available scientific evidence and are regularly updated to reflect new developments in the field. The guidelines are published in both the European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and they are available in Russian as well. The guidelines are designed to assist healthcare professionals in making informed decisions about the best treatment options for patients with myocardial revascularization needs.The 2018 ESC/EACTS guidelines on myocardial revascularization provide comprehensive recommendations for the diagnosis, treatment, and management of patients requiring myocardial revascularization. Developed by the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), with contributions from the European Association of Percutaneous Cardiovascular Interventions (EAPCI), these guidelines aim to improve clinical outcomes and quality of life for patients with coronary artery disease (CAD). The guidelines emphasize the importance of risk stratification, functional assessment of coronary lesions, and the selection of appropriate revascularization strategies, including percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Key recommendations include the use of fractional flow reserve (FFR) to assess the functional significance of coronary stenoses, the role of the heart team in decision-making, and the importance of risk-adapted treatment approaches. The guidelines also address specific patient populations, such as those with diabetes, chronic kidney disease, and those requiring valve surgery. They highlight the need for individualized care, considering the patient's overall clinical status and comorbidities. The guidelines emphasize the importance of evidence-based practice, with a focus on the latest clinical research and data. They also provide detailed recommendations on the use of antithrombotic therapy, the management of acute coronary syndromes, and the optimization of revascularization techniques. The guidelines are intended to be used in conjunction with other clinical guidelines and should not replace the judgment of individual clinicians. The recommendations are based on a thorough analysis of available scientific evidence and are regularly updated to reflect new developments in the field. The guidelines are published in both the European Heart Journal and the European Journal of Cardio-Thoracic Surgery, and they are available in Russian as well. The guidelines are designed to assist healthcare professionals in making informed decisions about the best treatment options for patients with myocardial revascularization needs.